Spasticity - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Spasticity -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Spasticity in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Spasticity. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Spasticity. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Spasticity sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Spasticity market.

  • Identifying prevalent patient populations as well as risk factors in the global Spasticity market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Spasticity therapeutics in each of the markets covered.

Spasticity - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Spasticity Overview
Spasticity Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Spasticity

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Spasticity
Sex-Specific Prevalent/Incident Cases of Spasticity
Disease Type Specific Prevalent/Incident Cases of Spasticity

8.Prevalent & Incident Cases by 7 MM-2015-2025
Spasticity Epidemiology of United States-2025
Spasticity Epidemiology of United Kingdom-2025
Spasticity Epidemiology of Germany-2025
Spasticity Epidemiology of France-2025
Spasticity Epidemiology of Spain-2025
Spasticity Epidemiology of Italy-2025
Spasticity Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Spasticity Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Spasticity (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Spasticity By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Spasticity Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Spasticity (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Spasticity By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Spasticity Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Spasticity (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Spasticity By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Spasticity Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Spasticity (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Spasticity By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Spasticity Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Spasticity (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Spasticity By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Spasticity Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Spasticity (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Spasticity By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Spasticity Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Spasticity (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Spasticity By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Spasticity Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Spasticity Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Spasticity (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Spasticity By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Spasticity Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Spasticity (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Spasticity By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Spasticity Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Spasticity (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Spasticity By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Spasticity Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Spasticity (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Spasticity By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Spasticity Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Spasticity (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Spasticity By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Spasticity Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Spasticity (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Spasticity By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Spasticity Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Spasticity (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Spasticity By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Spasticity Sub-population,Japan (2015-2025)
  • Global and Regional Gabapentin Market Research Report 2017
    Published: 17-Oct-2017        Price: US 3500 Onwards        Pages: 122
    Summary Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Tablet - Capsule By Application - Nerve Pain......
  • Rett Syndrome - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 120
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome - Pipeline Review, H2 2017, provides an overview of the Rett Syndrome (Central Nervous System) pipeline landscape.Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, Stage III, or the plateau and Stage IV, or the late motor deterioration stage. Symptoms i......
  • Guillain-Barre Syndrome - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 46
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Guillain-Barre Syndrome - Pipeline Review, H2 2017, provides an overview of the Guillain-Barre Syndrome (Central Nervous System) pipeline landscape.Guillain-Barre syndrome (GBS) is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances the symmetrica......
  • Narcolepsy - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 76
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape.Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling.......
  • Global Epilepsy Therapeutics Market Professional Survey Report 2017
    Published: 21-Sep-2017        Price: US 3500 Onwards        Pages: 101
    This report studies Epilepsy Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Abbott Laboratories - GlaxoSmithKline plc - Cephalon - Johnson......
  • Fragile X Syndrome - Pipeline Review, H2 2017
    Published: 19-Sep-2017        Price: US 2000 Onwards        Pages: 121
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fragile X Syndrome - Pipeline Review, H2 2017, provides an overview of the Fragile X Syndrome (Genetic Disorders) pipeline landscape.Fragile X syndrome is a genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment. Fragile X syndrome is caused by a change in a gene called FMR1. Fragile X syndrome occurs both in male and female. Symptoms include de......
  • Mild Cognitive Impairment - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 113
    Mild Cognitive Impairment - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment - Pipeline Review, H2 2017, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape. Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is an intermediate s......
  • Dyskinesia - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 147
    Dyskinesia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dyskinesia - Pipeline Review, H2 2017, provides an overview of the Dyskinesia (Central Nervous System) pipeline landscape. Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movement. Symptoms include facial grimacing, finger movement, jaw swinging, repetitive ......
  • Global Gabapentin Market Professional Survey Report 2017
    Published: 05-Sep-2017        Price: US 3500 Onwards        Pages: 105
    This report studies Gabapentin in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Pfizer - GSK - Sailike - Jiangsu Enhua - Jiangsu Hengrui - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs